These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1828639)

  • 1. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
    Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
    Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
    Perez M; Edelson R; Laroche L; Berger C
    J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
    Perez MI; Edelson RL; John L; Laroche L; Berger CL
    Yale J Biol Med; 1989; 62(6):595-609. PubMed ID: 2636801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA associated with the cell membrane is involved in the inhibition of the skin rejection response induced by infusions of photodamaged alloreactive cells that mediate rejection of skin allograft.
    Perez MI; Yamane Y; John L; Gasparro FP; Edelson RL
    Photochem Photobiol; 1992 Jun; 55(6):839-49. PubMed ID: 1409891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
    Brondz BD; Kazansky DB; Chernyshova AD; Ivanov VS
    Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).
    Ildstad ST; Bluestone JA; Sachs DH
    J Exp Med; 1986 May; 163(5):1343-8. PubMed ID: 2939173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts.
    Vermeer BJ; Santerse B; Van De Kerckhove BA; Schothorst AA; Claas FH
    Transplantation; 1988 Mar; 45(3):607-10. PubMed ID: 3126570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
    Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
    J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Sachs DH
    J Exp Med; 1985 Jul; 162(1):231-44. PubMed ID: 3159825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of anti-skin-allograft response by photodamaged effector cells--the modulating effects of prednisolone and cyclophosphamide.
    Yamane Y; Lobo FM; John LA; Edelson RL; Perez MI
    Transplantation; 1992 Jul; 54(1):119-24. PubMed ID: 1631919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
    Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
    Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.